Acute protection of ischemic heart by FGF-2: Involvement of FGF-2 receptors and protein kinase C

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 3 51-3, 2002, Pages

  Jiang, Zhi Sheng ^a   Padua, Raymond R ^a   Ju, Haisong ^a   Doble, Bradley W ^a   Jin, Yan ^a   Hao, Jianming ^a   Cattini, Peter A ^a   Dixon, Ian M C ^a   Kardami, Elissavet ^a  

^a Institute of Cardiovascular Sciences   (Canada)

Author keywords

Cardioprotection; Growth factors; Protein therapy; Reperfusion injury; Signal transduction

Indexed keywords

CHELERYTHRINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; ISOENZYME; MUTANT PROTEIN; PROTEIN KINASE C; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENERGY METABOLISM; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

EID: 0036081556     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00290.2001     Document Type: Article

References (50)

1. The late phase of preconditioning
2. Protein kinase C-α and -ε modulate connexin- 43 phosphorylation in human heart
3. Decrease of myocardial infarct size with desferrioxamine: Possible role of oxygen free radicals in its ameliorative effect
4. Protection of rat myocardium by mitogenic and non-mitogenic fibroblast growth factor during postischemic reperfusion
5. Cardioprotection from ischemia by fibroblast growth factor: Role of inducible nitric oxide synthase
6. Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury
7. Nitrendipine binding in congestive heart failure due to myocardial infarction
8. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes
9. The ε subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation
10. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis
11. Essential activation of PKC-δ in opioid-initiated cardioprotection
12. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion
13. The feasibility and safety of fluoroscopy-guided percutaneous intramyocardial gene injection in porcine heart
14. Basic FGF reduces stunning via a NOS 2-dependent pathway in coronary-perfused mouse hearts
15. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model
16. Regulation of vascular smooth muscle cell proliferation by nuclear factor-κB and its inhibitor, I-κB
17. Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium
18. Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: Evidence for isoform switching during heart development
19. Expression of Gq α and PLC-β in scar and border tissue in heart failure due to myocardial infarction
20. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
21. Oncogenic K-Ras and basic fibroblast growth factor prevent Fas-mediated apoptosis in fibroblasts through activation of mitogen-activated protein kinase
22. A rapid, two-step method for high-yield purification of recombinant rat acidic and basic fibroblast growth factors
23. Delivery strategies to achieve therapeutic myocardial angiogenesis
24. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
25. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart
26. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor
27. The pleiotropic effects of fibroblast growth factor receptors in mammalian development
28. + channels involves high-energy phosphate preservation
29. Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric oxide-dependent pathway in Nb 2 lymphoma cells
30. Increased basic fibroblast growth factor (bFGF) accumulation and distinct patterns of localization in isoproterenol-induced cardiomyocyte injury
31. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: Involvement of sarcolemmal calcium-independent protein kinase C
32. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury
33. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern
34. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection
35. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity
36. A fresh look at reperfusion injury
37. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that E is the isoform involved
38. Heparan sulfate proteoglycans as transducers of FGF-2 signaling
39. + through gap junctions
40. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
41. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
42. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts
43. Role of protein kinase C as a cellular mediator of ischemic preconditioning: A critical review
44. Clinical trials in coronary angiogenesis: Issues, problems, consensus. An expert panel summary
45. Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity
46. Cytoskeletal damage during myocardial ischemia: Changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart
47. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
48. Angiogenesis in ischemic heart disease
49. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: Distant dream or near reality?
50. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis